(Q53587240)
Statements
Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis. (English)
Harris RA
Kuppermann M
Richter JE
1 December 1997
92
12
2179-2187